"AstraZeneca, Bristol-Myers, Johnson & Johnson and Schering-Plough are defendants in a suit in Massachussetts and the litigation has revealed that they encouraged cancer docs to prescribe their drugs based on price rather than diagnosis."
Please read this post courtesy of NRx. It shows and links to other posts that Johnson and Johnson and several of the other BIG PHARMA companies show blatant disrespect for the economic well being of their U.S. consumer base. They show that they are looking at MDs as pure MARKETING AGENTS FOR THEIR OWN PROFITS (caps for emphasis only) and not PARTNERS in providing the safest and most efficacious health care for their consumers.
Tuesday, June 12, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment